Randomised, Opened, Multicentre Phase I/II Trial in Patients With Chronic Hepatitis B With HBV VL less than 12 IU/ml and Under Treatment With NRTI [nucleoside reverse transcriptase inhibitors], Which Evaluated Efficacy and Tolerance of Vaccination With Naked DNA on Viral Replication After Analogs' Treatment Interruption. ANRS HB02 VAC-ADN.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hepatitis B DNA vaccine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms VAC-ADN
- 19 Dec 2011 Biomarkers information updated
- 16 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.